FLT3 and acute myeloid leukemia: To further validate that FLT3-ITD mutated AML cells are more sensitive to OTS514, we evaluated cell cycle kinetics in MV4-11 and THP-1 cells treated with 20 nM of OTS514 compared with untreated cells.